In the context of liver disease, which factor primarily influences dose adjustments for medications?

• A. The patient’s age.
• B. The time since last meal.
• C. The stage of liver disease and reduced metabolism.
• D. The brand name of the drug.

Answer: (C)

Liver metabolism capacity is the key factor that guides drug dosing when liver disease is present. When the liver is damaged, its ability to metabolize medications decreases, especially for drugs that rely mainly on hepatic enzymes or hepatic clearance. As liver function worsens, drug exposure in the body increases, raising the risk of toxicity. To avoid this, doses are adjusted based on how advanced the liver impairment is (often using a classification of mild to severe), with smaller doses or longer dosing intervals for more severe impairment.

Age and meals can influence pharmacokinetics in general, and some drugs’ absorption or distribution might vary with food or age, but they do not drive dose adjustments in the context of liver disease the way reduced hepatic metabolism does. Brand name or formulation itself doesn’t determine how the liver processes a drug.